Citation Impact
Citing Papers
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice
2018 Standout
The role of TNF and its receptors in Alzheimer's disease
2001
Sjögren's syndrome
2005 Standout
Rheumatoid arthritis
2016 Standout
Synovial Tissue Inflammation Mediated by Autoimmune T Cells
2019 StandoutNobel
Polymyalgia rheumatica and giant-cell arteritis
2008
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
2009 Standout
EPIDEMIOLOGY OF THE VASCULITIDES
2001
Ischemic optic neuropathy
2008 Standout
Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period
2001
Trial of Tocilizumab in Giant-Cell Arteritis
2017 Standout
The Erythrocyte Sedimentation Rate Is Associated with the Development of Visual Complications in Biopsy-Proven Giant Cell Arteritis
2008
Immune mechanisms in medium and large-vessel vasculitis
2013
Experience with infliximab (anti-TNFα monoclonal antibody) as monotherapy for giant cell arteritis
2003
BSR and BHPR guidelines for the management of giant cell arteritis
2010
Stroke associated with giant cell arteritis: a population-based study
2014
Treatment of longstanding active giant cell arteritis with infliximab: Report of four cases
2001
An atlas of genetic correlations across human diseases and traits
2015 Standout
Sexual dimorphism in innate immunity
2002
Clinical features of polymyalgia rheumatica and giant cell arteritis
2012
Treatment of refractory temporal arteritis with adalimumab
2006
Risk factors for visual loss in an Italian population‐based cohort of patients with giant cell arteritis
2005
Rheumatic Manifestations of Infective Endocarditis in Non-Addicts
2001
A strong initial systemic inflammatory response is associated with higher corticosteroid requirements and longer duration of therapy in patients with giant‐cell arteritis
2002
The genetics of primary Sjögren’s syndrome
2003
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases
2009
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part II
2007 Standout
Polymyalgia Rheumatica and Giant-Cell Arteritis
2002 Standout
Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990–2001
2006
Sex differences in immune responses
2016 Standout
The fast-track ultrasound clinic for early diagnosis of giant cell arteritis significantly reduces permanent visual impairment: towards a more effective strategy to improve clinical outcome in giant cell arteritis?
2015
HLA–DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis
2007
Epidemiology and genetics of rheumatoid arthritis.
2002
Dispensable roles of Gsdmd and Ripk3 in sustaining IL-1β production and chronic inflammation in Th17-mediated autoimmune arthritis
2021 StandoutNobel
Fibroblast‐like synoviocytes: key effector cells in rheumatoid arthritis
2009 Standout
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Influence of human leukocyte antigen-DRB1 on the susceptibility and severity of rheumatoid arthritis
2002
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Giant-Cell Arteritis and Polymyalgia Rheumatica
2003
Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial.
2007
Giant Cell Arteritis versus Takayasu Arteritis: An Update
2020
Loss of the Protein Tyrosine Phosphatase PTPN22 Reduces Mannan-Induced Autoimmune Arthritis in SKG Mice
2016 StandoutNobel
Inflammation as a central mechanism in Alzheimer's disease
2018 Standout
Polymyalgia Rheumatica and Giant Cell Arteritis
1978
A role for fungal β-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice
2005 StandoutNobel
Colour-duplex ultrasonography of the temporal and ophthalmic arteries in the diagnosis and follow-up of giant cell arteritis.
2010
2015 ESC Guidelines for the management of infective endocarditis
2015 Standout
Impaired T cell receptor signaling and development of T cell–mediated autoimmune arthritis
2020 StandoutNobel
Works of Adèle Dababneh being referenced
Visual Manifestations of Giant Cell Arteritis: Trends and Clinical Spectrum in 161 Patients
2000
Different gene loci within the HLA‐DR and TNF regions are independently associated with susceptibility and severity in Spanish rheumatoid arthritis patients
2000
Association of giant cell arteritis and polymyalgia rheumatica with different tumor necrosis factor microsatellite polymorphisms
2000
Interferon-gamma gene microsatellite polymorphisms in patients with biopsy-proven giant cell arteritis and isolated polymyalgia rheumatica.
2004
The spectrum of polymyalgia rheumatica in northwestern Spain: incidence and analysis of variables associated with relapse in a 10 year study.
1999
Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HLA class II association.
1998
Association between HLA-DRB1*15 and secondary Sjögren's syndrome in patients with rheumatoid arthritis.
2000
Seronegative rheumatoid arthritis in elderly and polymyalgia rheumatica have similar patterns of HLA association.
2001
IL-6 promoter polymorphism at position -174 modulates the phenotypic expression of polymyalgia rheumatica in biopsy-proven giant cell arteritis.
2003
Patients chosen for treatment with cyclosporine because of severe rheumatoid arthritis are more likely to carry HLA-DRB1 shared epitope alleles, and have earlier disease onset.
2002